FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
36.03 EUR
-1.07 (-2.88%)
FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 30 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FME get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on FME. FME also has an excellent dividend rating. With these ratings, FME could be worth investigating further for value and dividend investing!.
1. Profitability
1.1 Basic Checks
- FME had positive earnings in the past year.
- In the past year FME had a positive cash flow from operations.
- In the past 5 years FME has always been profitable.
- In the past 5 years FME always reported a positive cash flow from operatings.
1.2 Ratios
- FME has a Return On Assets (2.33%) which is in line with its industry peers.
- FME has a Return On Equity (5.55%) which is comparable to the rest of the industry.
- With a Return On Invested Capital value of 3.95%, FME perfoms like the industry average, outperforming 43.33% of the companies in the same industry.
- FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 6.46%.
- The last Return On Invested Capital (3.95%) for FME is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
- Looking at the Profit Margin, with a value of 3.66%, FME is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
- FME's Profit Margin has declined in the last couple of years.
- FME's Operating Margin of 7.19% is fine compared to the rest of the industry. FME outperforms 66.67% of its industry peers.
- FME's Operating Margin has declined in the last couple of years.
- FME has a Gross Margin (25.00%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of FME has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
- FME has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, FME has about the same amount of shares outstanding.
- The number of shares outstanding for FME has been reduced compared to 5 years ago.
- FME has a better debt/assets ratio than last year.
2.2 Solvency
- FME has an Altman-Z score of 2.13. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
- FME has a Altman-Z score (2.13) which is comparable to the rest of the industry.
- FME has a debt to FCF ratio of 5.97. This is a neutral value as FME would need 5.97 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 5.97, FME is doing good in the industry, outperforming 76.67% of the companies in the same industry.
- A Debt/Equity ratio of 0.73 indicates that FME is somewhat dependend on debt financing.
- FME has a Debt to Equity ratio of 0.73. This is in the better half of the industry: FME outperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 2.13 |
ROIC/WACC0.7
WACC5.68%
2.3 Liquidity
- A Current Ratio of 1.36 indicates that FME should not have too much problems paying its short term obligations.
- FME has a better Current ratio (1.36) than 70.00% of its industry peers.
- FME has a Quick Ratio of 1.36. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a decent Quick ratio value of 1.00, FME is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 16.77% over the past year.
- Measured over the past years, FME shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.43% on average per year.
- Looking at the last year, FME shows a small growth in Revenue. The Revenue has grown by 2.10% in the last year.
- FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
- FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.37% yearly.
- Based on estimates for the next years, FME will show a small growth in Revenue. The Revenue will grow by 3.81% on average per year.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 9.58, the valuation of FME can be described as very reasonable.
- FME's Price/Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 90.00% of the companies in the same industry.
- FME is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 8.69 indicates a reasonable valuation of FME.
- FME's Price/Forward Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 86.67% of the companies in the same industry.
- FME's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.29.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.58 | ||
| Fwd PE | 8.69 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as FME.
- FME's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. FME is cheaper than 63.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.05 | ||
| EV/EBITDA | 9.88 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as FME's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
- FME has a Yearly Dividend Yield of 3.90%. Purely for dividend investing, there may be better candidates out there.
- The stock price of FME dropped by -21.21% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- Compared to an average industry Dividend Yield of 1.73, FME pays a better dividend. On top of this FME pays more dividend than 96.67% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.84, FME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.9% |
5.2 History
- The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
- 58.83% of the earnings are spent on dividend by FME. This is a bit on the high side, but may be sustainable.
- FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
FRA:FME (1/20/2026, 1:41:30 PM)
36.03
-1.07 (-2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners43.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.14B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.86
Price Target47.55 (31.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.9% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-0.64%
PT rev (3m)-5.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.64%
EPS NY rev (1m)0.17%
EPS NY rev (3m)3.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.58 | ||
| Fwd PE | 8.69 | ||
| P/S | 1.08 | ||
| P/FCF | 12.05 | ||
| P/OCF | 8.42 | ||
| P/B | 1.63 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.88 |
EPS(TTM)3.76
EY10.44%
EPS(NY)4.15
Fwd EY11.51%
FCF(TTM)2.99
FCFY8.3%
OCF(TTM)4.28
OCFY11.88%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.44
PEG (5Y)N/A
Graham Number43.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.13 |
F-Score5
WACC5.68%
ROIC/WACC0.7
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.33%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status for FME stock?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.
Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.
What is the valuation of FRESENIUS MEDICAL CARE AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 9.58 and the Price/Book (PB) ratio is 1.63.
How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 58.83%.